Research work · 2016

GABAergic Synchronization in Epilepsy

Roustem Khazipov

Cold Spring Harbor Perspectives in Medicine

Abstract

g-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the cerebral cortex.GABAergic inhibition enables synchronization of activity in cortical networks, and contributes to generation of variety of brain activity patterns.In relation to epilepsy, GABAergic inhibition has been traditionally viewed as the main mechanism counterbalancing glutamatergic excitation and preventing hypersynchronous neuronal discharges.Indeed, deficits in GABAergic functions most commonly result in a hyperexcitable epileptic state, and many of the currently used antiepileptic drugs act through enhancement of GABAergic functions.However, a number of observations show that some epileptiform activity patterns involve synchronization by GABAergic mechanisms.These include two main categories that will be reviewed here: (1) synchronization of epileptiform oscillations based on GABAergic inhibition, and (2) epileptiform events driven by depolarizing and excitatory GABA.The conclusion is reached that GABAergic control of spike timing, either through inhibition or excitation under certain conditions, may work as a powerful synchronizing mechanism during epilepsy.g -Amino butyric acid (GABA) is the main inhibitory neurotransmitter in the cerebral cortex.GABAergic inhibition enables synchronization of activity in neuronal networks, and contributes to the generation of a variety of brain-activity patterns, sets the temporal window for integration of excitatory inputs, and controls synaptic plasticity (Freund and Buzsaki 1996;Buzsaki 2006;Klausberger and Somogyi 2008).GABAergic inhibition has long been considered as the main brake in the neuronal networks that prevents generation and spread of paroxysmal activities (Trevelyan and Schevon 2013).Considerable evidence indicates that inherent or acquired deficiency in GABAergic functions result in epilepsy (Lerche et al. 2013).Blockade of GABAergic inhibition in healthy brain results in acute epileptic discharges, and blockers of GABA receptors, including penicillin, pentylenetetrazole (PTZ), and bicuculline, are widely used as experimental epilepsy models (Curtis et al. 1970;Connors 1984;Miles and Wong 1987).In addition, drugs enhancing GABAergic inhibition most commonly alleviate seizures.These include positive allosteric modulators of GABA A receptors, benzodiazepines and barbiturates, and drugs that inhibit GABA uptake, such as tiagabine, or GABA degradation, such as vigabatrin.However, GABAergic involvement in epileptic phenomena may be more complex than one could assume from a simple look at GABA as an endogenous anti-

Download PDF

DOI: 10.1101/cshperspect.a022764